Preferences
Related Series
Related Segments
Ambulatory Clearinghouse 2014
Choosing Between Strong Performers
Clearinghouse vendors have some of the highest-performing solutions that KLAS monitors. However, there are differences, and this report is focused on helping providers make the best purchasing decisions for their specific circumstances.
WORTH KNOWING
SMALL CUSTOMERS CAN HARDLY GO WRONG:
Smaller clinics looking to select a clearinghouse have a lot of great choices: Availity, Capario, Gateway, Navicure, Office Ally, Practice Insight, and ZirMed all perform exceptionally for smaller organizations. Smaller Allscripts and Emdeon customers are generally satisfied, while smaller Optum and RelayHealth customers are less satisfied. GE has fewer small respondents, whose satisfaction is lower as well.
THE DIFFERENCE IS OFTEN CONSISTENT, QUALITY SERVICE:
ZirMed leads a tight grouping of vendors, including Navicure, Office Ally, Practice Insight, Gateway, Capario, and Availity, who all offer a consistently positive customer experience. Emdeon and RelayHealth customers generally say the tools meet their needs, but the support experience varies widely. Optum customers also report inconsistency. For customers switching vendors, service was the most-cited reason.Â
EARLY DATA INDICATES NOT EVERYONE CAN GO BIG:
The majority of the KLAS clearinghouse data has come from smaller clinics, but early data from larger organizations (>30 physicians) indicates that not all vendors scale. GE was the one vendor whose feedback primarily came from larger clinics, who rated GE significantly higher than smaller customers did. Availity and RelayHealth also had many large respondents. Larger Capario, Navicure, and ZirMed customers are equally satisfied. Conversely, larger Emdeon customers struggled. KLAS encountered few larger organizations using Gateway, Office Ally, Optum, or Practice Insight.
BOTTOM LINE ON VENDORS
DIRECT CONTRACTUAL RELATIONSHIPS
PRO: Customer-focused support, more proactive outreach (Optum an exception)
 CON: Extra vendors/contracts to deal with
ALLSCRIPTS
Mostly Allscripts PM, medium variability, good mix of large/ small respondents
AVAILITY (REALMED)
PM agnostic, medium variability, good mix of large/ small respondents
GATEWAY EDI
PM agnostic, low variability, few large respondents
GE HEALTHCARE
GE PMs only, medium variability, large customers very satisfied, few small respondents
NAVICURE
PM agnostic, low variability, mostly small to midsize respondents
OFFICE ALLY
PM agnostic, low score variability, payer financed, respondents mostly smaller clinics in West
OPTUM
PM agnostic, high variability, few large respondents
ZIRMED
PM agnostic, low variability, most respondents small to midsize practices Â
INDIRECT CONTRACTUAL RELATIONSHIPS
PRO: Single contract with PM vendor
 CON: Less customer-focused proactive support (Practice Insight an exception), potential for finger-pointing with PM vendor
PRACTICE INSIGHT
PM agnostic, many Aprima and Henry Schein PMÂ customers,medium variability, few large respondents
RELAYHEALTH
PM agnostic, high variability, good mix of large/small respondents
BOTH DIRECT AND INDIRECT CONTRACTUALÂ RELATIONSHIPS
CAPARIO
PM agnostic, medium variability, larger and smaller organizations very satisfied
EMDEON
PM agnostic for indirect and eCW PM for direct, high variability— large, multispecialty customers less satisfied
(Note: KLAS’ Emdeon sample is largely indirect)
Clearinghouse vendors have some of the highest-performing solutions that Klas Monitors. However, there are differences, and this report is focused on helping providers make the best purchasing decisions for their specific circumstances.
Project Manager
Robert Ellis
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.